Your address will show here +12 34 56 78

Thyroid and parathyroid surgery are two common surgical procedures that have become very safe thanks to the surgical advances. However, hypoparathyroidism remains the current concern of thyroid surgery.
New fluorescence imagining techniques, have been developed to help the detection of parathyroid glands and confirm their vascularization. This has opened a new exciting area of research for surgeons and scientists.
Moreover, our fluorescence imagining system FLUOEAM® has received the market authorization from FDA to help in real-time localization of parathyroid tissue during procedures such as thyroidectomy or parathyroidectomy.
In this context, we are delighted to see you at this first international symposium and to present to you our fluorescence imaging solutions and their various applications.
We also invite you to our symposium presented by Mrs. Odile ALLARD the CEO of Fluoptics© and Mr. Philippe RIZO the CTO of Fluoptics©, which is based on the latest Fluoptics© innovations. This symposium will take place on February 28th from 6 to 7 pm.